Related Articles
PRMT1 expression predicts sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma
Prognostic values of transketolase family genes in ovarian cancer
p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers
Expression of UCP2 is associated with sensitivity to platinum‑based chemotherapy for ovarian serous carcinoma
Prognostic significance of the mitochondrial scoring system in ovarian cancer